Clayton Financial Group LLC Novartis Ag Transaction History
Clayton Financial Group LLC
- $273 Billion
- Q1 2025
A detailed history of Clayton Financial Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Clayton Financial Group LLC holds 2,013 shares of NVS stock, worth $226,019. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,013
Previous 2,166
7.06%
Holding current value
$226,019
Previous $211 Million
6.47%
% of portfolio
0.08%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.33 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.17 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$966 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$792 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$759 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $242B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...